Thierry Chauche
Financieel Directeur/CFO bij SAGIMET BIOSCIENCES INC.
Oorsprong van het eerstegraads netwerk van Thierry Chauche
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
| Subsidiary | Pharmaceuticals: Major | 9 | |
| Subsidiary | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thierry Chauche via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Director/Board Member Founder | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
| The University of Manchester | College/University | Doctorate Degree | |
| Princeton University | College/University | Doctorate Degree | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Undergraduate Degree | |
Los Alamos National Laboratory
 Los Alamos National Laboratory Miscellaneous Commercial ServicesCommercial Services Los Alamos National Laboratory operates as a multidisciplinary institution. It offers services in science, engineering, earth science, chemistry, mathematics, physics, and space science. The company was founded in 1943 and is headquartered in Los Alamos, NM. | Miscellaneous Commercial Services | Director/Board Member | |
| Federal University of Rio de Janeiro | College/University | Corporate Officer/Principal | |
| University College Cork | College/University | Undergraduate Degree | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| United States Navy (District of Columbia) | Sovereign | Corporate Officer/Principal | |
Trustees of Thayer Academy
 Trustees of Thayer Academy Miscellaneous Commercial ServicesCommercial Services The Thayer Academy provides educational services. It regulates student enrollment requirements and establishes educational standards, procedures, and curriculum. The firm offers college preparatory education that attracts students from diverse social, ethnic, economic, and academic backgrounds. The company was founded in 1877 and is headquartered in Braintree, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| DNAX Research, Inc. | Corporate Officer/Principal | ||
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chief Administrative Officer Human Resources Officer | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | General Counsel Corporate Officer/Principal | |
| Harvard Law School | College/University | Graduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Biotechnology | Director/Board Member | |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Chief Executive Officer Compliance Officer | |
BC XII Private Investors (Lux) SCSP
 BC XII Private Investors (Lux) SCSP Investment ManagersFinance BC XII Private Investors (Lux), SCSp operates as private equity fund. The company is headquartered in Findel, Luxembourg. | Investment Managers | Chief Executive Officer | |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member | |
| Martins Bruno Consulting LLC | Founder | ||
| JDRF New England Chapter | President | ||
| New York University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Verenigd Koninkrijk | 2 |
| Israël | 2 |
| Brazilië | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Health Services | 3 |
| Finance | 3 |
Operationeel
| Corporate Officer/Principal | 80 |
| Director/Board Member | 75 |
| Independent Dir/Board Member | 22 |
| Undergraduate Degree | 22 |
| Chief Tech/Sci/R&D Officer | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| Beth Seidenberg | 39 |
| Jinzi Wu | 20 |
| David Happel | 15 |
| Jeffrey Bluestone | 14 |
| Rita Jain | 14 |
| Richard Rodgers | 13 |
| Susan Altschuller | 12 |
| Benedict Osorio | 12 |
| Sean N. Doherty | 12 |
| Merdad Parsey | 11 |
| John V. W. Reynders | 11 |
| Eduardo Bruno Martins | 10 |
| Andrew Drechsler | 10 |
| Anne-Marie O'Farrell | 9 |
| Heidy Abreu King-Jones | 8 |
- Beurs
- Insiders
- Thierry Chauche
- Bedrijfsconnecties
